Evogene Ltd. current report, Q2 FY2021

Business Context and Reporting Period

This Form 6-K filing by Evogene Ltd. covers the month of June 2021, with a specific reporting date of June 23, 2021. The filing serves to disclose a significant change in corporate governance rather than financial results.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate announcement and does not contain financial statements or performance metrics.

Material Changes

The primary material change disclosed is the appointment of Ms. Sarit Firon as the new Chairperson of the Board. This announcement was made via a press release furnished as Exhibit 99.1.

Guidance, Outlook, and Risks

The filing does not contain management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. The document focuses solely on the leadership transition.

Key Facts for Investors to Verify

  • Confirmation of Ms. Sarit Firon's appointment as Chairperson of the Board.
  • Review of the full press release (Exhibit 99.1) for details on the transition and any statements from outgoing leadership.
  • Verification of the impact of this governance change on the company's strategic direction, as no financial data is included in this specific filing.